Investor
Opportunities
At Cloaked Therapeutics, we are reimagining cancer treatment. Our proprietary TumorSelect platform delivers chemotherapy directly to tumors while sparing healthy tissue, unlocking safer, more effective therapies and a multi-billion-dollar market opportunity.
Give Hope. Fund Breakthroughs.
Imagine a world where cancer therapy brings healing without debilitating side effects. At Cloaked Therapeutics, our TumorSelect platform uses LDL-mimicking nanoparticles to deliver life-saving drugs directly to tumors while sparing healthy tissue. As an early-stage pharmaceutical company with strong preclinical results, a clear regulatory path, and access to a rapidly growing oncology market, we are poised to transform both patient outcomes and investor potential.
Turn Hope Into Healing
Imagine the breakthroughs your gift could spark. Hope grows when we act together.
- Your support fuels innovation and brings us closer to safer, more effective cancer therapies.
- Every contribution helps transform imagination into real solutions for patients and families worldwide.
- Together, we can reimagine the future of cancer care — one breakthrough at a time.
Our Mission
To use our proprietary LDL technology to create new chemotherapeutics that selectively target tumors and thereby improve tolerability and efficacy of known molecules as well as enable novel ones.
Our Vision
To transform cancer treatment by providing a targeted, effective, and patient-friendly solution. TumorSelect is designed to save lives by selectively attacking cancer cells while preserving healthy tissue, reducing the debilitating side effects of traditional therapies.